Latest Insider Transactions at Sensei Biotherapeutics, Inc. (SNSE)
This section provides a real-time view of insider transactions for Sensei Biotherapeutics, Inc. (SNSE). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Sensei Biotherapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Sensei Biotherapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 28
2021
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
11,288
+0.23%
|
$56,440
$5.28 P/Share
|
|
Dec 27
2021
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
3,712
+0.08%
|
$18,560
$5.3 P/Share
|
|
Dec 27
2021
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
3,712
+0.08%
|
$18,560
$5.3 P/Share
|
|
Dec 23
2021
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
11,000
+0.23%
|
$55,000
$5.27 P/Share
|
|
Dec 23
2021
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
11,000
+0.23%
|
$55,000
$5.27 P/Share
|
|
Dec 17
2021
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
117
+0.0%
|
$585
$5.29 P/Share
|
|
Dec 17
2021
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
117
+0.0%
|
$585
$5.29 P/Share
|
|
Dec 16
2021
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
10,925
+0.23%
|
$54,625
$5.25 P/Share
|
|
Dec 16
2021
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
10,925
+0.23%
|
$54,625
$5.25 P/Share
|
|
Dec 10
2021
|
Thomas G Ricks |
BUY
Open market or private purchase
|
Indirect |
20,000
+5.53%
|
$100,000
$5.86 P/Share
|
|
Dec 09
2021
|
Thomas G Ricks |
BUY
Open market or private purchase
|
Indirect |
20,000
+5.85%
|
$120,000
$6.62 P/Share
|
|
Aug 11
2021
|
Robert Hamilton Pierce Chief R&D Officer |
SELL
Open market or private sale
|
Indirect |
16,030
-100.0%
|
$112,210
$7.34 P/Share
|
|
Aug 10
2021
|
Robert Hamilton Pierce Chief R&D Officer |
SELL
Open market or private sale
|
Indirect |
66,350
-80.54%
|
$464,450
$7.13 P/Share
|
|
Aug 09
2021
|
Robert Hamilton Pierce Chief R&D Officer |
SELL
Open market or private sale
|
Indirect |
6,982
-7.81%
|
$48,874
$7.06 P/Share
|
|
Aug 06
2021
|
Robert Hamilton Pierce Chief R&D Officer |
SELL
Open market or private sale
|
Indirect |
6,460
-6.74%
|
$45,220
$7.11 P/Share
|
|
May 05
2021
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
350
+0.01%
|
$4,200
$12.0 P/Share
|
|
May 05
2021
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
350
+0.01%
|
$4,200
$12.0 P/Share
|
|
Apr 20
2021
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
385
+0.01%
|
$4,620
$12.77 P/Share
|
|
Apr 20
2021
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
385
+0.01%
|
$4,620
$12.77 P/Share
|
|
Apr 19
2021
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
1,965
+0.04%
|
$25,545
$13.38 P/Share
|
|
Apr 19
2021
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
1,965
+0.04%
|
$25,545
$13.38 P/Share
|
|
Apr 13
2021
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
2,000
+0.04%
|
$28,000
$14.0 P/Share
|
|
Apr 13
2021
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
2,000
+0.04%
|
$28,000
$14.0 P/Share
|
|
Apr 07
2021
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
2,000
+0.04%
|
$28,000
$14.0 P/Share
|
|
Apr 07
2021
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
2,000
+0.04%
|
$28,000
$14.0 P/Share
|
|
Apr 01
2021
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
1,000
+0.02%
|
$14,000
$14.0 P/Share
|
|
Apr 01
2021
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
1,000
+0.02%
|
$14,000
$14.0 P/Share
|
|
Mar 30
2021
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
2,000
+0.04%
|
$24,000
$12.0 P/Share
|
|
Mar 30
2021
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
2,000
+0.04%
|
$24,000
$12.0 P/Share
|
|
Mar 24
2021
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
3,750
+0.08%
|
$52,500
$14.12 P/Share
|
|
Mar 24
2021
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
3,750
+0.08%
|
$52,500
$14.12 P/Share
|
|
Mar 23
2021
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
10,000
+0.21%
|
$140,000
$14.34 P/Share
|
|
Mar 23
2021
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
10,000
+0.21%
|
$140,000
$14.34 P/Share
|
|
Mar 22
2021
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
2,183
+0.05%
|
$32,745
$15.02 P/Share
|
|
Mar 22
2021
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
2,183
+0.05%
|
$32,745
$15.02 P/Share
|
|
Mar 18
2021
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
817
+0.02%
|
$12,255
$15.25 P/Share
|
|
Mar 18
2021
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
817
+0.02%
|
$12,255
$15.25 P/Share
|
|
Mar 08
2021
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
1,000
+0.02%
|
$15,000
$15.25 P/Share
|
|
Mar 08
2021
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
1,000
+0.02%
|
$15,000
$15.25 P/Share
|
|
Mar 05
2021
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
8,000
+0.17%
|
$104,000
$13.75 P/Share
|
|
Mar 05
2021
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
8,000
+0.17%
|
$104,000
$13.75 P/Share
|
|
Mar 04
2021
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
2,000
+0.04%
|
$28,000
$14.12 P/Share
|
|
Mar 04
2021
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
2,000
+0.04%
|
$28,000
$14.12 P/Share
|
|
Mar 03
2021
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
3,000
+0.06%
|
$45,000
$15.85 P/Share
|
|
Mar 03
2021
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
3,000
+0.06%
|
$45,000
$15.85 P/Share
|
|
Mar 02
2021
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
3,000
+0.06%
|
$48,000
$16.25 P/Share
|
|
Mar 02
2021
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
3,000
+0.06%
|
$48,000
$16.25 P/Share
|
|
Feb 26
2021
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
5,000
+0.1%
|
$80,000
$16.25 P/Share
|
|
Feb 26
2021
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
5,000
+0.1%
|
$80,000
$16.25 P/Share
|
|
Feb 25
2021
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
12,000
+0.25%
|
$180,000
$15.79 P/Share
|